Abstract:Background Chronic hepatitis B is a primary cause of liver-related death. Interferon alpha (IFN-α) is able to inhibit the replication of hepadnavirus, and the sustained and stable expression of IFN-α at appropriate level may be beneficial to HBV clearance. With the development of molecular cloning technology, gene therapy plays a more and more important role in clinical practice. In light of the findings, an attempt to investigate the anti-HBV effects mediated by a eukaryotic expression plasmid (pSecTagB-IFN-α) in vitro was carried out. Methods HBV positive cell line HepG2.2.15 and its parental cell HepG2 were transfected with pSecTagB-IFN-α or empty plasmid by using Lipofectamine™ 2000 reagent. The expression levels of IFN-α were determined by reverse transcriptase polymerase chain reaction (RT-PCR) and ELISA methods. The effects of pSecTagB-IFN-α on HBV mRNA, DNA and antigens were analyzed by real-time fluorescence quantitative PCR (qRT-PCR) and ELISA assays. RT-PCR, qRT-PCR and western blot were employed to investigate the influence of pSecTagB-IFN-α on IFN-α-induced signal pathway. Furthermore, through qRT-PCR and ELISA assays, the suppressive effects of endogenously expressed IFN-α and the combination with lamivudine on HBV were also examined. Results pSecTagB-IFN-α could express efficiently in hepatoma cells, and then inhibited HBV replication, characterized by the decrease of HBV S gene (HBs) and HBV C gene (HBc) mRNA, the reduction of HBV DNA load, and the low contents of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg). Mechanism research showed that the activation of Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signal pathway, the up-regulation of IFN-α-induced antiviral effectors and double-stranded (ds) RNA sensing receptors by delivering pSecTagB-IFN-α, could be responsible for these phenomena. Furthermore, pSecTagB-IFN-α vector revealed effectively anti-HBV effect than exogenously added IFN-α. Moreover, lamivudine combined with endogenously expressed IFN-α exhibited stronger anti-HBV effect than with exogenous IFN-α. Conclusion Our results showed that endogenously expressed IFN-α can effectively and persistently inhibit HBV replication in HBV infected cells. These observations opened a promising way to design new antiviral genetic engineering drugs based on IFN-α.

Construction of HMGN2 recombinant expression plasmid and its anti-βhepatitis virus activity

Anti -hepatitis activity comparison between extracted and recombinant high mobility group chromosal protein N2

Inhibitory effect of HMGN2 protein on human hepatitis B viral HBeAg and HBsAg expression and DNA replication in HBV-transformed HepG2. 2.15 cell line

Construction of recombinant vector of HBVP22~e gene and its expression in HepG2 cells

Construction and Expression of Hepatitis B Virus Envelope Protein Combined with Core Protein with Two Multiple Cloning Sites Vector

[Construction of Eukaryotic Expression Vector Expressing Hepatitis B Virus HBsAg and EGFP Fusion Protein and Establishment of Stable Transfected Chang Liver Cell Line].

Construction, identification and biological feature study of human hepatocellular carcinoma cells stably expressing HBeAg

Construction of Eukaryotic Expressional Vectors of APOBEC3G and the Effects on the Replication and Expression of HBV

Construction of Eukaryotic Expression Plasmids of Hepatitis B Surface Antigen and Helper T Lymphocyte Epitope

Construction of a recombinant plasmid expressing HBV core antigen and A3C fusion protein

Construction and Expression of Eukaryotic Expression Plasmid of Core Gene of Hepatitis C Virus

Construction of Shuttle Expression Vector of Pre-S1 Gene and Truncated Core Gene of Hepatitis B Virus

Construction of a Plasmid of HBV Core Antigen-EGFP Fusion Protein and Its Expression in Hep G2 Cell

Prokaryotic Expression of a Novel Therapeutic recombinant transbody H2L2 Targeting Hepatitis B Virus core protein

Construction of Pichia Pastoris Expressive Vectors of Two New Hepatitis B Surface Antigen Genes and Expression

Construction and expression of recombinant eukaryotic expression vector containing hepatitis B virus surface antigen gene

Construction and Identification of Small Hairpin RNA Vector Targeting HBV Core Protein in HepG2.2.15 Cells

The Anti-Hbv Effect Mediated by a Novel Recombinant Eukaryotic Expression Vector for IFN-α

Construction of a 1.2-genome length genotype C HBV construct and study on its expression and replication in HepG2 cells

Construction of a Pcdna-Hbeag Expression Vector to Express HBeAg in CHO Cells

Construction and Expression of Recombinant HBx-expressed Adenovirus and HBx Expression in HepG2